Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has informed BSE that its Board of Directors will meet on Friday, 14th November 2025 at its registered office in Ahmedabad. The main agenda item is to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th September 2025. Any other incidental business may also be taken up with the Chair's permission. The trading window for dealing in the company's securities has been closed since 1st October 2025 and will reopen 48 hours after the results are declared.
This is a routine regulatory filing and does not contain any financial figures. Shareholders should watch for the actual results on or after 14th November 2025, as the numbers could move the stock. The closed trading window signals that insiders are barred from trading until results are published.